LAMTOR1 and breast carcinoma: This is in agreement with the finding that mTOR inhibition increases NMT1 expression in breast cancer cells47, possibly due to a compensatory mechanism to increase LAMTOR1 myristoylation and restore mTORC1 activity in cells treated with mTOR inhibitors.